Peptide Receptor Types Explained

Peptides bind to various receptor types on cells, triggering different biological responses. The major families are G-protein-coupled receptors (GPCRs), receptor tyrosine kinases (RTKs), and ion-channel receptors. Each family has distinct mechanisms of activation and different downstream signalling pathways.

Understanding receptor type helps predict what biological effects a peptide might produce.

GPCRs are the largest family of receptors, with over 800 members. They span the cell membrane seven times. When a peptide ligand binds, the GPCR changes shape and activates an intracellular G-protein, which then activates downstream signalling cascades. GLP-1 receptors, ghrelin receptors, and many other hormone receptors are GPCRs.

GPCRs are activated and then desensitized when continuously exposed to ligand, a process important for understanding tachyphylaxis and drug tolerance.

RTKs are activated when a ligand binds to the extracellular domain, causing the receptor to dimerize (pair with another copy) and autophosphorylate (add phosphate groups to itself). This phosphorylation creates docking sites for intracellular signalling proteins, activating multiple signalling pathways including MAPK/ERK and PI3K/Akt pathways.

Growth factors and some peptides activate RTKs, which regulate cell growth, survival, and differentiation.

Ion-channel receptors are membrane proteins with a central pore that allows specific ions (sodium, calcium, potassium) to flow across the cell membrane when activated. Some peptides modulate ion-channel activity. Ion-channel activation produces rapid electrical effects on cell excitability.

Different receptor types produce different kinetics and magnitude of effects. GPCR activation is relatively slow (seconds) but prolonged. RTK activation is rapid and triggers growth signals. Ion-channel effects are very rapid (milliseconds) and affect cell excitability. The receptor type a peptide binds determines the characteristics of its biological effect.